Martin Shkreli
martin@martinshkreli.com
←
|
NBIX.xlsx
|
Main
Model
Ingrezza
A
B
C
1
Main
2
Brand
Ingrezza
3
Generic
valbenazine
4
Indication
Tardive Dyskinesia
5
MOA
VMAT2 inhibitor
6
IP
8357697 - MOU for hyperkinetic disorder - expires 11/08/2027
7
8038627 - COM - expires 2031 (adjusted for H-W)
Martin Shkreli